This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
The FDA has authorized the first wearable device that continuously monitors ketone levels in people with type 1 diabetes, according to JAMA. The supplied report does not give details on availability or use.
HOW THIS BRIEF WAS MADE 1 outlet: 1 specialist. Automated sourcing and summaries by the BLUF engine. Corrections
The authorization is relevant to people with type 1 diabetes and the clinicians who care for them in the United States. The supplied information does not describe the device’s price, coverage or expected effect on care.
The supplied report does not state when the device will be available or provide further details about its use.
When the device becomes available
Details on cost, insurance coverage and clinical use